U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470788) titled 'FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation' on March 09.
Brief Summary: This first-in-human study evaluates the safety and performance of the Vesalius Transcatheter Mitral Valve Repair (TMVr) System in patients with degenerative mitral regurgitation. The study will enroll patients who are at high or prohibitive risk for conventional surgical repair or replacement of the mitral valve. Participants will receive implantation of the Vesalius TMVr System and will be followed to assess clinical outcomes, device performance, and any adverse events.
Study Start Date: March, 2026
Study Type: INT...